Of all the subjects, only 7 presented with signals that did not conform to the neuropathological staging of tau deposition.57 [18F]AV-1451 has since been used to measure neurodegeneration and patterns of tau pathology in AD, MCI, and older healthy controls compared to younger healthy controls.58–62. The gene discussed is MAPT; the disease is Alzheimer disease.